WASHINGTON (Reuters) – Canada’s health ministry said on Friday it had authorized the use of Pfizer Inc’s and BioNTech’s coronavirus vaccine as a booster for children five to 11 years old.
(Reporting by Tim Ahmann; editing by Paul Grant)
Canada OKs Pfizer-BioNTech COVID-19 booster dose for 5 to 11 year olds
Aug 19, 2022 | 10:36 AM
